Larimar Therapeutics, Inc.Larimar Therapeutics, Inc.Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc.

No trades
See on Supercharts

Larimar Therapeutics, Inc. SEC filings and other documents


Explore the latest company documents and SEC filings from Larimar Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
Description
Event date
Documents and forms
2025
Q2 2025
Aug 14, 2025
Quarterly report10-Q
Earnings release8-K
Status Update
Jun 23, 2025
Slides
Press release
Corporate Presentation
Jun 23, 2025
Slides
Q1 2025
Apr 30, 2025
Quarterly report10-Q
Earnings release8-K
2024
Q4 2024
Mar 24, 2025
Annual report10-K
Earnings release8-K
Study Update
Dec 16, 2024
Press release
Slides
Corporate Presentation
Oct 30, 2024
Slides
Q3 2024
Oct 30, 2024
Quarterly report10-Q
Earnings release8-K
Q2 2024
Aug 7, 2024
Quarterly report10-Q
Earnings release8-K
Q1 2024
May 9, 2024
Quarterly report10-Q
Earnings release8-K
2023
Q4 2023
Mar 14, 2024
Earnings release8-K
Annual report10-K
Q3 2023
Nov 14, 2023
Quarterly report10-Q
Earnings release8-K
Q2 2023
Aug 10, 2023
Quarterly report10-Q
Earnings release8-K
Q1 2023
May 15, 2023
Quarterly report10-Q
Earnings release8-K
2022
Q4 2022
Mar 14, 2023
Earnings release8-K
Annual report10-K
Q3 2022
Nov 10, 2022
Quarterly report10-Q
Earnings release8-K
Q2 2022
Aug 11, 2022
Quarterly report10-Q
Earnings release8-K
Q1 2022
May 12, 2022
Quarterly report10-Q
Earnings release8-K
2021
Q4 2021
Mar 25, 2022
Earnings release8-K
Annual report10-K
Q3 2021
Nov 12, 2021
Quarterly report10-Q
Earnings release8-K
Q2 2021
Aug 12, 2021
Quarterly report10-Q
Earnings release8-K
Q1 2021
May 10, 2021
Quarterly report10-Q
Earnings release8-K
2020
Q4 2020
Mar 4, 2021
Annual report10-K
2019
Q4 2019
Mar 5, 2020
Annual report10-K
2018
Q4 2018
Mar 14, 2019
Annual report10-K
2017
Q4 2017
Mar 9, 2018
Annual report10-K
2016
Q4 2016
Mar 10, 2017
Annual report10-K
2015
Q4 2015
Mar 15, 2016
Annual report10-K
2014
Q4 2014
Mar 25, 2015
Annual report10-K